Clinical trials for Cancer in United States

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

Study ID: NCT03659448

Sponsor

Surgimab

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Study ID: NCT06401330

Sponsor

Children's Oncology Group

RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy

Study ID: NCT03524430

Sponsor

Rna Diagnostics Inc.

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Study ID: NCT05791448

Sponsor

University of Southern California

Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

Study ID: NCT02619448

Sponsor

State University of New York - Upstate Medical University

Physical Activity Monitoring in Myasthenia Gravis

Study ID: NCT06277830

Sponsor

Massachusetts General Hospital

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

Study ID: NCT06253130

Sponsor

Eikon Therapeutics

CHARGE Study: CHoice ARchitecture Genetic tEsting

Study ID: NCT06284330

Sponsor

University of Texas Southwestern Medical Center

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

Study ID: NCT05037825

Sponsor

Fixed biome

Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma

Study ID: NCT05004025

Sponsor

HonorHealth Research Institute